Fluorine in PDB 5sol: Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000910475722 - (S,R) Isomer

Enzymatic activity of Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000910475722 - (S,R) Isomer

All present enzymatic activity of Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000910475722 - (S,R) Isomer:
3.4.19.121;

Protein crystallography data

The structure of Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000910475722 - (S,R) Isomer, PDB code: 5sol was solved by G.J.Correy, J.S.Fraser, with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å) 44.33 / 1.05
Space group P 43
Cell size a, b, c (Å), α, β, γ (°) 88.655, 88.655, 39.358, 90, 90, 90
R / Rfree (%) 14.6 / 16.3

Fluorine Binding Sites:

The binding sites of Fluorine atom in the Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000910475722 - (S,R) Isomer (pdb code 5sol). This binding sites where shown within 5.0 Angstroms radius around Fluorine atom.
In total only one binding site of Fluorine was determined in the Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000910475722 - (S,R) Isomer, PDB code: 5sol:

Fluorine binding site 1 out of 1 in 5sol

Go back to Fluorine Binding Sites List in 5sol
Fluorine binding site 1 out of 1 in the Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000910475722 - (S,R) Isomer


Mono view


Stereo pair view

A full contact list of Fluorine with other atoms in the F binding site number 1 of Pandda Analysis Group Deposition -- Crystal Structure of Sars-Cov-2 NSP3 Macrodomain in Complex with ZINC000910475722 - (S,R) Isomer within 5.0Å range:
probe atom residue distance (Å) B Occ
A:F201

b:21.1
occ:0.36
F19 A:WVM201 0.0 21.1 0.4
O A:HOH443 1.1 16.4 0.6
C18 A:WVM201 1.3 19.6 0.4
O A:HOH442 1.8 14.0 0.6
H151 A:WVM201 2.2 21.6 0.4
C21 A:WVM201 2.3 20.4 0.4
H201 A:WVM201 2.3 21.9 0.4
C20 A:WVM201 2.4 18.2 0.4
C14 A:WVM201 2.4 18.6 0.4
O23 A:WVM201 2.6 20.6 0.4
C15 A:WVM201 2.6 18.0 0.4
H202 A:WVM201 2.7 21.9 0.4
H A:VAL49 2.8 13.2 0.6
H A:ILE131 2.8 17.0 0.6
O A:HOH519 2.9 33.4 0.6
HA3 A:GLY130 2.9 17.8 0.6
HA3 A:GLY48 3.0 14.5 0.6
HG12 A:ILE131 3.0 26.5 0.4
HA3 A:GLY48 3.0 15.6 0.4
HG12 A:ILE131 3.1 19.8 0.6
H171 A:WVM201 3.2 22.4 0.4
HG23 A:VAL49 3.2 16.7 0.6
HA2 A:GLY48 3.3 14.5 0.6
C17 A:WVM201 3.3 18.6 0.4
H A:VAL49 3.3 14.5 0.4
H152 A:WVM201 3.4 21.6 0.4
N12 A:WVM201 3.4 17.4 0.4
C16 A:WVM201 3.5 18.5 0.4
CA A:GLY48 3.5 12.1 0.6
N A:VAL49 3.5 11.0 0.6
C13 A:WVM201 3.5 18.3 0.4
HA2 A:GLY48 3.5 15.6 0.4
O22 A:WVM201 3.5 20.8 0.4
H162 A:WVM201 3.6 22.2 0.4
N A:ILE131 3.6 14.2 0.6
HD13 A:ILE131 3.6 26.9 0.4
H A:ILE131 3.6 23.2 0.4
O A:HOH407 3.7 13.1 0.6
CA A:GLY48 3.7 13.0 0.4
O A:HOH501 3.8 30.4 0.6
CA A:GLY130 3.8 14.8 0.6
CG1 A:ILE131 3.9 22.1 0.4
HG23 A:ILE131 3.9 19.6 0.6
HG23 A:ILE131 3.9 26.0 0.4
HG23 A:VAL49 3.9 15.9 0.4
HE1 A:PHE132 4.0 24.3 0.4
HD1 A:PHE132 4.0 23.9 0.4
C A:GLY48 4.0 11.2 0.6
CG1 A:ILE131 4.0 16.5 0.6
N A:VAL49 4.0 12.1 0.4
CD1 A:ILE131 4.1 22.4 0.4
O A:ALA129 4.1 12.7 0.6
CG2 A:VAL49 4.1 13.9 0.6
H131 A:WVM201 4.1 22.0 0.4
H172 A:WVM201 4.1 22.4 0.4
HD11 A:ILE131 4.1 26.9 0.4
H132 A:WVM201 4.2 22.0 0.4
C A:GLY130 4.2 14.5 0.6
O A:HOH344 4.3 18.9 0.6
O A:HOH420 4.3 10.9 0.4
HB A:VAL49 4.3 15.3 0.6
HA3 A:GLY130 4.3 22.1 0.4
HD1 A:PHE132 4.3 14.8 0.6
HA2 A:GLY130 4.4 17.8 0.6
H161 A:WVM201 4.4 22.2 0.4
C A:GLY48 4.4 12.6 0.4
HG13 A:ILE131 4.4 26.5 0.4
HG13 A:ILE131 4.4 19.8 0.6
N A:ILE131 4.4 19.3 0.4
O A:HOH394 4.4 12.2 0.6
HG21 A:VAL49 4.5 16.7 0.6
H A:PHE132 4.5 15.4 0.6
CB A:VAL49 4.6 12.7 0.6
O A:HOH531 4.6 33.4 0.6
CA A:VAL49 4.6 11.2 0.6
N A:GLY130 4.6 14.0 0.6
CE1 A:PHE132 4.6 20.2 0.4
C08 A:WVM201 4.6 15.9 0.4
H071 A:WVM201 4.7 18.1 0.4
CB A:ILE131 4.7 15.4 0.6
CD1 A:PHE132 4.7 19.9 0.4
CG2 A:ILE131 4.7 16.3 0.6
CA A:ILE131 4.7 13.9 0.6
C A:ALA129 4.7 12.8 0.6
HD13 A:ILE131 4.7 21.3 0.6
CG2 A:ILE131 4.7 21.6 0.4
HG22 A:VAL49 4.7 16.7 0.6
CB A:ILE131 4.8 21.4 0.4
N A:GLY48 4.8 12.6 0.6
CD1 A:ILE131 4.8 17.7 0.6
HB A:VAL49 4.8 15.3 0.4
HD11 A:ILE131 4.8 21.3 0.6
N A:GLY48 4.9 13.7 0.4
CG2 A:VAL49 4.9 13.2 0.4
O A:ALA129 4.9 17.6 0.4
HG21 A:ILE131 5.0 26.0 0.4

Reference:

S.Gahbauer, G.J.Correy, M.Schuller, M.P.Ferla, Y.U.Doruk, M.Rachman, T.Wu, M.Diolaiti, S.Wang, R.J.Neitz, D.Fearon, D.Radchenko, Y.Moroz, J.J.Irwin, A.R.Renslo, J.C.Taylor, J.E.Gestwicki, F.Von Delft, A.Ashworth, I.Ahel, B.K.Shoichet, J.S.Fraser. Structure-Based Inhibitor Optimization For the NSP3 Macrodomain of Sars-Cov-2. Biorxiv 2022.
ISSN: ISSN 2692-8205
PubMed: 35794891
DOI: 10.1101/2022.06.27.497816
Page generated: Tue Apr 4 23:51:05 2023

Last articles

Zn in 8WB0
Zn in 8WAX
Zn in 8WAU
Zn in 8WAZ
Zn in 8WAY
Zn in 8WAV
Zn in 8WAW
Zn in 8WAT
Zn in 8W7M
Zn in 8WD3
© Copyright 2008-2020 by atomistry.com
Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy